课题基金 / 基金详情

Molecular structure and function of uridine receptor regulating sleep

Molecular structure and function of uridine receptor regulating sleep
调节睡眠的尿苷受体的分子结构和功能
批准号:
13672311
负责人:
KIMURA Toshiyuki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

KIMURA Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
已知嘧啶核苷包括尿苷具有中枢神经系统(CNS)抑制作用,例如小鼠中的催眠活性。本文合成了嘧啶核苷的N^3-苄基和苯甲酰甲基衍生物,并通过小鼠侧脑室注射研究了它们对中枢神经系统的药理作用。我们已经发现,N^3-苄基或苯甲酰甲基取代的尿苷和阿拉伯呋喃糖基尿嘧啶在500 nmol/小鼠的剂量下在小鼠中发挥抗伤害感受活性。对尿苷类衍生物的构效关系进行了系统的研究,以寻找更强的抗伤害性化合物,某些衍生物如邻-或对-氟苄基-,邻,间,对-氯苯甲基-,邻,间,对-溴苄基,对-氯苯甲酰甲基取代的阿拉伯呋喃糖基尿嘧啶显示出12-58 min的小鼠睡眠时间。此外,o-氟苄基-和o,p-溴苄基-阿拉伯呋喃糖基尿嘧啶显着增强戊巴比妥诱导的睡眠。特别是对氯苯甲酰甲基和对溴苯甲酰甲基衍生物比N^3-苯甲酰甲基尿苷具有更强的抗伤害活性。然而,除了N^3-(对氯苄基)尿苷外,没有N^3-苄基尿苷衍生物显示出抗伤害感受活性。N^3-(2 ',5' -二甲氧基苯甲酰甲基)尿苷在小鼠中也表现出抗伤害感受活性。将N,3-苯甲酰尿苷-6-碳酸与Affigel 102和碳二亚胺偶联,制备亲和柱,用于纯化尿苷受体。
英文摘要
The pyrimidine nucleosides including uridine are known to have central nervous system (CNS) depressant effects, such as hypnotic activity in mice. N^3-Benzyl and phenacyl derivatives of pyrimidine nucleosides were synthesized and their pharmacological effects on the CNS have been studied by intracerebroventricular injection to mice. We have found that N^3-benzyl or phenacyl substituted uridine and arabinofuranosyluracil exert antinociceptive activity in mice at a dose of 500 nmol/mouse. Systematic studies on structure-activity relationship of uridine related derivatives were performed to find stronger antinociceptive compounds, so that certain derivatives such as o- or p-fluorobenzyl-, o, m, p-chlo ; robenzyl-, o, m, p-bromobenzyl, p-chlorophenacyl substituted arabinofuranosyluracils exhibited 12-58 min of mice sleeping time. Moreover, o-fluorobenzyl- and o, p-bromobenzyl-arabinofuranosyluracils significantly potentiated pentobarbiral-induced sleep. Especially, p-chloro and p-bromo phenacyl derivatives exerted more potent antinociceptive activity than that of N^3-phenacyluridine. However, none of the N^3-benzyluridine derivatives except for N^3-(p-chlorobenzyl)uridine showed the antinociceptive activity. N^3-(2', 5' -dimethoxyphenacyl)uridine also exerted antinociceptive activities in mice. N^3-Phenacyluridine-6-carbonic acid was coupled with Affigel 102 and carbodiimide to prepare affinity column for using prurification of uridine receptor.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
K. Watanabe, T. Matsunaga, T. Kimura, T. Funahashi, Y. Funae, T. Ohshima, I. Yamamoto: "Major cytochrome P450 enzyme responsible for aldehyde oxygenation of 11-oxo-□^8-tetrahydrocannabinol and 9-anthralaldehyde in human liver"Drug Metabolism and Pharmacok
K. Watanabe、T. Matsunaga、T. Kimura、T. Funahashi、Y. Funae、T. Ohshima、I. Yamamoto:“主要细胞色素 P450 酶负责 11-oxo-□^8-四氢大麻酚和 9-人体肝脏中的蒽醛《药物代谢与药理学》
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Kimura, I.K.Ho, I.Yamamoto: "Uridine receptor : Discovery and its involvement in sleep mechanism"Sleep. 24. 251-260 (2001)
T.Kimura、I.K.Ho、I.Yamamoto:“尿苷受体:发现及其参与睡眠机制”睡眠。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S. Kozai, T. Maruyama, T. Kimura, and I. Yamamoto: "Synthesis and hypnotic activities of 4-thio analogues of N^3-substituted uridines"Chem. Pharm. Bull.. 49. 1185-1188 (2001)
S. Kozai、T. Maruyama、T. Kimura 和 I. Yamamoto:“N^3-取代尿苷的 4-硫代类似物的合成和催眠活性”Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Kimura, M.Miki, M.Ikeda, S.Yonemoto, K.Watanabe, S.Kondo, I.K.Ho, I.Yamamoto: "Possible existence of a novel receptor for undine analogues in the central nervous system using two isomers, N3-(S)-(+)-and N3-(R)-(-)-a-phenethyl-b-hydroxyuridines"Biol. Pha
T.Kimura、M.Miki、M.Ikeda、S.Yonemoto、K.Watanabe、S.Kondo、I.K.Ho、I.Yamamoto:“中枢神经系统中可能存在一种新的 undine 类似物受体,使用两种异构体,
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 12 条
    Preparation of 15N labled 1-deoxynojirimycin and evaluation of its absorption and organ migration
    Mass production of 15N labeled DNJ to evaluate the absorption and excretion of 1-deoxynojirimycin
    Hypnotic and antinociceptive effects of N3-substituted oxopyrimidines and their mechanism
    • 批准号:
      15590075
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2003
    • 负责人:
      KIMURA Toshiyuki
    • 依托单位:
    国内基金
    海外基金
    长期间歇性缺氧抑制呼吸运动神经长时程易化的分子机制
    • 批准号:
      81141002
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2011
    • 负责人:
      张成
    • 依托单位:
    中枢钠氢交换蛋白3在睡眠呼吸暂停呼吸控制稳定性中的作用和调控机制
    • 批准号:
      30900646
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2009
    • 负责人:
      马靖
    • 依托单位: